Nexentis Technologies Inc.
NXTS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001789192
No open-market purchases or sales by Nexentis Technologies Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $272.3K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Nexentis Technologies Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Nexentis Technologies Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lee Eun Young | 10% Owner | 479,524 | Mar 26, 2026 | 1 |
| Zakai Shlomo | Controller | 64,778Indirect | Feb 11, 2026 | 1 |
| Weiss Amitay | Director | 129,144Indirect | Feb 11, 2026 | 1 |
| Palach David | Chief Executive Officer | 129,144Indirect | Feb 11, 2026 | 1 |
| Barda Lital | Chief Financial Officer | 64,370Indirect | Feb 11, 2026 | 1 |
| Berenstein Israel Yakov | Director | 64,500 | Dec 26, 2024 | 0 |
| Rosenbloom Ronen | Director | 64,500 | Dec 26, 2024 | 0 |
| Arbib Eliahou | Director | 64,500 | Dec 26, 2024 | 0 |
| Kalifi Udi Ovadia | Director | 68,457 | Dec 26, 2024 | 0 |
| Sidi Liat | Director | 50,000 | Dec 26, 2024 | 0 |
| Itzhaik Asaf | Director | 50,000 | Dec 26, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 (view filing) | Jan 29 | 56 daysLate | Lee Eun Young10% Owner | SSaleCommon Stock, par value $0.0001 per share | −127 | $1.36 | −$172.72 | 0.0%479.5K after | |
| Dec 26, 2024 (view filing) | Dec 23 | 3 days | Rosenbloom RonenDirector | PPurchaseRestricted Shares of Common Stock | +50.0K | $0.00 | $0 | +344.8%64.5K after | |
| Dec 26, 2023 (view filing) | Dec 20 | 6 daysLate | Weiss AmitayDirector | PPurchaseRestricted Shares of Common Stock | +100.0K | $0.00 | $0 | New position100.0K after | |
| Dec 26, 2023 (view filing) | Dec 20 | 6 daysLate | Rosenbloom RonenDirector | PPurchaseRestricted Shares of Common Stock | +14.5K | $0.00 | $0 | New position14.5K after | |
| Dec 26, 2023 (view filing) | Dec 20 | 6 daysLate | Kalifi Udi OvadiaDirector | PPurchaseRestricted Shares of Common Stock | +14.5K | $0.00 | $0 | +366.4%18.5K after | |
| Dec 26, 2023 (view filing) | Dec 20 | 6 daysLate | Berenstein Israel YakovDirector | PPurchaseRestricted Shares of Common Stock | +14.5K | $0.00 | $0 | New position14.5K after | |
| Dec 26, 2023 (view filing) | Dec 20 | 6 daysLate | Arbib EliahouDirector | PPurchaseRestricted Shares of Common Stock | +14.5K | $0.00 | $0 | New position14.5K after | |
| Jul 26, 2022 (view filing) | Jun 15-16 | 41 daysLate | Kalifi Udi OvadiaDirector | PPurchase | +27.7K | $3.25 | +$90.1K | New position27.7K after | 2 lots |